Vinge Logotype
Svenska English 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises EOS Russia
Mandate

Vinge advises EOS Russia

May 30, 2008

Vinge has been advising and representing EOS Russia in connection with the completion of the company’s series of share issues, directed to investors in Sweden and abroad. The offer was effectuated through “reoccurring demand driven pricing and settlement” and, following completion of the offer, the total proceeds of issue amounted to approximately SEK 2.1 billion. Participating banks in the transaction were Troika Dialog and Carnegie.

The Vinge team principally included Lena Almefelt, Rikard Stenberg, Petter Alberts, Henrik Fritz, Andreas Johard and Johan Thiman.

Related

Vinge advises SAGA Diagnostics AB on convertible note issue

 SAGA Diagnostics AB, a cancer diagnostics and disease monitoring company, has carried out a convertible note issue of approximately SEK 144 million. Vinge advised SAGA Diagnostics in connection with the transaction.
September 28, 2023

Vinge advises Repligen Corporation in connection with the acquisition of Metenova

 Vinge has advised Repligen Corporation and subsidiaries ("Repligen"), a multinational life sciences group that develops and commercializes highly innovative bioprocess technologies and systems that enable efficiency in the biopharmaceutical manufacturing process, in connection with its acquisition of Metenova Holding AB with subsidiaries (“Metenova”).
September 27, 2023

Vinge has advised private equity firm Stirling Square Capital Partners

 Vinge has advised private equity firm Stirling Square Capital Partners in connection with its acquisition of a majority stake in Infobric, a leading provider of software solutions for the construction industry, from Summa Equity.
September 22, 2023